{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:13:56Z","timestamp":1780881236633,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic proliferative retinopathy (IPR), such as proliferative diabetic retinopathy (PDR), retinal vein occlusion and retinopathy of prematurity is a major cause of vision loss. Our previous studies demonstrated that periostin (PN) and tenascin-C (TNC) are involved in the pathogenesis of IPR. However, the interactive role of PN and TNC in angiogenesis associated with IPR remain unknown. We found significant correlation between concentrations of PN and TNC in PDR vitreous humor. mRNA and protein expression of PN and TNC were found in pre-retinal fibrovascular membranes excised from PDR patients. Interleukin-13 (IL-13) promoted mRNA and protein expression of PN and TNC, and co-immunoprecipitation assay revealed binding between PN and TNC in human microvascular endothelial cells (HRECs). IL-13 promoted angiogenic functions of HRECs. Single inhibition of PN or TNC and their dual inhibition by siRNA suppressed the up-regulated angiogenic functions. Pathological pre-retinal neovessels of oxygen-induced retinopathy (OIR) mice were attenuated in PN knock-out, TNC knock-out and dual knock-out mice compared to wild-type mice. Both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>, PN inhibition had a stronger inhibitory effect on angiogenesis compared to TNC inhibition, and had a similar effect to dual inhibition of PN and TNC. Furthermore, PN knock-out mice showed scant TNC expression in pre-retinal neovessels of OIR retinas. Our findings suggest that interaction of PN and TNC facilitates pre-retinal angiogenesis, and PN is an effective therapeutic target for IPR such as PDR.<\/jats:p>","DOI":"10.1038\/s41598-020-66278-1","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T10:02:46Z","timestamp":1591696966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy"],"prefix":"10.1038","volume":"10","author":[{"given":"Yuki","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4200-0052","authenticated-orcid":false,"given":"Shintaro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Hisatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Haruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"66278_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee, P., Wang, C. C. & Adamis, A. P. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 43, 3 (1998).","journal-title":"Surv Ophthalmol."},{"key":"66278_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/112067211002000604","volume":"20","author":"SE Hern\u00e1ndez-Da Mota","year":"2010","unstructured":"Hern\u00e1ndez-Da Mota, S. E. & Nu\u00f1ez-Solorio, S. M. Experience with intravitreal bevacizumab as a preoperative adjunct in 23-G vitrectomy for advanced proliferative diabetic retinopathy. Eur. J. Ophthalmol. 20, 1047\u20131052 (2010).","journal-title":"Eur. J. Ophthalmol."},{"key":"66278_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1136\/bjophthalmol-2017-311344","volume":"102","author":"XY Zhao","year":"2018","unstructured":"Zhao, X. Y., Xia, S. & Chen, Y. X. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: A meta-analysis of randomised controlled trials. Br. J. Ophthalmol. 102, 1077\u20131085 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"66278_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2016.04.003","volume":"167","author":"M Beck","year":"2016","unstructured":"Beck, M., Munk, M. R., Ebneter, A., Wolf, S. & Zinkernagel, M. S. Retinal Ganglion Cell Layer Change in Patients Treated With Anti-Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration. Am. J. Ophthalmol. 167, 10\u201317 (2016).","journal-title":"Am. J. Ophthalmol."},{"key":"66278_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima, K. et al. Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury. Am. J. Pathol. 171, 53\u201367 (2007).","journal-title":"Am. J. Pathol."},{"key":"66278_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","volume":"96","author":"RJ Van Geest","year":"2012","unstructured":"Van Geest, R. J. et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br. J. Ophthalmol. 96, 587\u2013590 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"66278_CR7","first-page":"1202","volume":"8","author":"J-K Li","year":"2015","unstructured":"Li, J.-K. et al. Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab. Int. J. Ophthalmol. 8, 1202\u20131206 (2015).","journal-title":"Int. J. Ophthalmol."},{"key":"66278_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/bjophthalmol-2015-308199","volume":"100","author":"Q Zhang","year":"2016","unstructured":"Zhang, Q. et al. The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: Clinical and laboratory evidence. Br. J. Ophthalmol. 100, 1443\u20131450 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"66278_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bjo.2007.127142","volume":"92","author":"JF Arevalo","year":"2008","unstructured":"Arevalo, J. F. et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br. J. Ophthalmol. 92, 213\u2013216 (2008).","journal-title":"Br. J. Ophthalmol."},{"key":"66278_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1167\/iovs.14-15589","volume":"56","author":"K Ishikawa","year":"2015","unstructured":"Ishikawa, K. et al. Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 56, 932\u2013946 (2015).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"66278_CR11","first-page":"1","volume":"9","author":"L Ling","year":"2014","unstructured":"Ling, L., Cheng, Y., Ding, L. & Yang, X. Association of serum periostin with cardiac function and short-term prognosis in acute myocardial infarction patients. PLoS One. 9, 1\u20138 (2014).","journal-title":"PLoS One."},{"key":"66278_CR12","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/all.13437","volume":"73","author":"Y Mitamura","year":"2018","unstructured":"Mitamura, Y. et al. The IL-13\/periostin\/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation. Allergy. 73, 1881\u20131891 (2018).","journal-title":"Allergy."},{"key":"66278_CR13","doi-asserted-by":"publisher","first-page":"40148","DOI":"10.18632\/oncotarget.9512","volume":"7","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk\/VEGF signaling. Oncotarget. 7, 40148\u201340159 (2016).","journal-title":"Oncotarget."},{"key":"66278_CR14","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2967\/jnumed.109.071340","volume":"51","author":"J Taki","year":"2010","unstructured":"Taki, J. et al. Dynamic Expression of Tenascin-C After Myocardial Ischemia and Reperfusion: Assessment by 125I-Anti-Tenascin-C Antibody Imaging. J. Nucl. Med. 51, 1116\u20131122 (2010).","journal-title":"J. Nucl. Med."},{"key":"66278_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jdermsci.2005.06.001","volume":"40","author":"K Ogawa","year":"2005","unstructured":"Ogawa, K., Ito, M., Takeuchi, K. & Nakada, A. Tenascin-C is upregulated in the skin lesions of patients with atopic dermatitis. J Dermatol Sci. 40, 35\u201341 (2005).","journal-title":"J Dermatol Sci."},{"key":"66278_CR16","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1038\/onc.2008.155","volume":"27","author":"A Calvo","year":"2008","unstructured":"Calvo, A. et al. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene. 27, 5373\u20135384 (2008).","journal-title":"Oncogene."},{"key":"66278_CR17","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1167\/iovs.10-6625","volume":"52","author":"S Yoshida","year":"2011","unstructured":"Yoshida, S. et al. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 52, 5670\u20135678 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"66278_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.13-229740","volume":"28","author":"K Ishikawa","year":"2014","unstructured":"Ishikawa, K. et al. Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J. 28, 131\u2013142 (2014).","journal-title":"FASEB J."},{"key":"66278_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.omtn.2017.01.004","volume":"6","author":"T Nakama","year":"2017","unstructured":"Nakama, T. et al. Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization. Mol. Ther. Nucleic Acids. 6, 279\u2013289 (2017).","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"66278_CR20","first-page":"436","volume":"22","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi, Y. et al. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy. Mol. Vis. 22, 436\u201345 (2016).","journal-title":"Mol. Vis."},{"key":"66278_CR21","first-page":"3466","volume":"35","author":"RB Brem","year":"1994","unstructured":"Brem, R. B. et al. Immunolocalization of integrins in the human retina. Invest. Ophthalmol. Vis. Sci. 35, 3466\u20133474 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"66278_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1172\/JCI25964","volume":"116","author":"A Uemura","year":"2006","unstructured":"Uemura, A. et al. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J. Clin. Invest. 116, 369\u2013377 (2006).","journal-title":"J. Clin. Invest."},{"key":"66278_CR23","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1242\/dev.071381","volume":"138","author":"D Stenzel","year":"2011","unstructured":"Stenzel, D. et al. Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. Development. 138, 4451\u20134463 (2011).","journal-title":"Development."},{"key":"66278_CR24","first-page":"3475","volume":"35","author":"SG Robbins","year":"1994","unstructured":"Robbins, S. G. et al. Immunolocalization of Integrins in Proliferative Retinal Membranes. Invest. Ophthalmol. Vis. Sci. 35, 3475\u20133485 (1994).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"66278_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0014-4835(05)80079-X","volume":"60","author":"RP Casaroli Marano","year":"1995","unstructured":"Casaroli Marano, R. P., Preissner, K. T. & Vilar\u00f3, S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp. Eye Res. 60, 5\u201317 (1995).","journal-title":"Exp. Eye Res."},{"key":"66278_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/bjo.2006.109199","volume":"91","author":"D McLeod","year":"2007","unstructured":"McLeod, D. et al. A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage. Br. J. Ophthalmol. 91, 677\u2013689 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"66278_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","volume":"118","author":"G Takayama","year":"2006","unstructured":"Takayama, G. et al. Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J. Allergy Clin. Immunol. 118, 98\u2013104 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"66278_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12079-017-0422-6","volume":"12","author":"A Kudo","year":"2018","unstructured":"Kudo, A. & Kii, I. Periostin function in communication with extracellular matrices. J. Cell Commun. Signal. 12, 301\u2013308 (2018).","journal-title":"J. Cell Commun. Signal."},{"key":"66278_CR29","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1074\/jbc.M109.051961","volume":"285","author":"I Kii","year":"2009","unstructured":"Kii, I. et al. Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture. J. Biol. Chem. 285, 2028\u20132039 (2009).","journal-title":"J. Biol. Chem."},{"key":"66278_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.yexmp.2014.10.007","volume":"97","author":"AE Sirica","year":"2014","unstructured":"Sirica, A. E., Almenara, J. A. & Li, C. Periostin in intrahepatic cholangiocarcinoma: Pathobiological insights and clinical implications. Exp. Mol. Pathol. 97, 515\u2013524 (2014).","journal-title":"Exp. Mol. Pathol."},{"key":"66278_CR31","doi-asserted-by":"crossref","unstructured":"Yoshida, S. et al. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation. Br. J. Ophthalmol. 1\u20136 (2015).","DOI":"10.1136\/bjophthalmol-2014-305860"},{"key":"66278_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. & Ratcliffe, P. J. Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway. Mol. Cell. 30, 393\u2013402 (2008).","journal-title":"Mol. Cell."},{"key":"66278_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","volume":"86","author":"S Rey","year":"2010","unstructured":"Rey, S. & Semenza, G. L. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc. Res. 86, 236\u2013242 (2010).","journal-title":"Cardiovasc. Res."},{"key":"66278_CR34","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.4049\/jimmunol.165.5.2818","volume":"165","author":"J Fukushi","year":"2000","unstructured":"Fukushi, J. et al. The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13. J. Immunol. 165, 2818\u20132823 (2000).","journal-title":"J. Immunol."},{"key":"66278_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biomaterials.2018.06.003","volume":"178","author":"BJ Kwee","year":"2018","unstructured":"Kwee, B. J. et al. CD4 T-cells regulate angiogenesis and myogenesis. Biomaterials. 178, 109\u2013121 (2018).","journal-title":"Biomaterials."},{"key":"66278_CR36","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cellsig.2017.10.019","volume":"42","author":"K Takagi","year":"2018","unstructured":"Takagi, K. et al. IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424 \/ 503 in vitro. Cell. Signal. 42, 270\u2013280 (2018).","journal-title":"Cell. Signal."},{"key":"66278_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn, T. A. Type 2 cytokines: mechanisms and therapeutic strategies. Nat. Rev. Immunol. 15, 271\u2013282 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"66278_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2006.11.019","volume":"184","author":"S Hendrix","year":"2007","unstructured":"Hendrix, S. & Nitsch, R. The role of T helper cells in neuroprotection and regeneration. J. Neuroimmunol. 184, 100\u2013112 (2007).","journal-title":"J. Neuroimmunol."},{"key":"66278_CR39","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/ar.22985","volume":"297","author":"K Imanaka-yoshida","year":"2014","unstructured":"Imanaka-yoshida, K. & Yoshida, T. Tenascin-C in Development and Disease of Blood Vessels. Anat. Rec. 297, 1747\u20131757 (2014).","journal-title":"Anat. Rec."},{"key":"66278_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0002-9394(88)90240-1","volume":"105","author":"MW John","year":"1988","unstructured":"John, M. W., Juan, E. D. & Machemer, R. Ultrastructural Characteristics of New Vessels in Proliferative Diabetic Retinopathy. Am. J. Ophthalmol. 105, 491\u2013499 (1988).","journal-title":"Am. J. Ophthalmol."},{"key":"66278_CR41","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1167\/iovs.07-1356","volume":"49","author":"Y Saito","year":"2008","unstructured":"Saito, Y., Uppal, A., Byfield, G., Budd, S. & Hartnett, M. E. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest Ophthalmol Vis Sci. 49, 1591\u20131598 (2008).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"66278_CR42","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1167\/iovs.10-5176","volume":"51","author":"A Stahl","year":"2010","unstructured":"Stahl, A. et al. The Mouse Retina as an Angiogenesis Model. Invest Ophthalmol Vis Sci. 51, 2813\u20132826 (2010).","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"66278_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/gt.2014.112","volume":"22","author":"T Nakama","year":"2015","unstructured":"Nakama, T. et al. Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin. Gene Ther. 22, 127\u2013137 (2015).","journal-title":"Gene Ther."},{"key":"66278_CR44","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1001\/jama.2015.15217","volume":"314","author":"W Network","year":"2015","unstructured":"Network, W. C. for the D. R. C. R. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial. JAMA 314, 2137\u20132146 (2015).","journal-title":"JAMA"},{"key":"66278_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10384-016-0481-x","volume":"61","author":"Y Ogura","year":"2017","unstructured":"Ogura, Y. et al. Clinical practice pattern in management of diabetic macular edema in Japan: survey results of Japanese retinal specialists. Jpn. J. Ophthalmol. 61, 43\u201350 (2017).","journal-title":"Jpn. J. Ophthalmol."},{"key":"66278_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-017-0537-6","volume":"62","author":"H Terasaki","year":"2018","unstructured":"Terasaki, H., Ogura, Y., Kitano, S., Sakamoto, T. & Murata, T. Management of diabetic macular edema in Japan: a review and expert opinion. Jpn. J. Ophthalmol. 62, 1\u201323 (2018).","journal-title":"Jpn. J. Ophthalmol."},{"key":"66278_CR47","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha, S. et al. Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON A Multicenter Cohort Study (SEVEN-UP). Ophthalmology. 120, 2292\u20132299 (2013).","journal-title":"Ophthalmology."},{"key":"66278_CR48","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565\u20131573 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66278-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:01:19Z","timestamp":1670328079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66278"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66278-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"16 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9299"}}